Stock Pick

  • India’s Zydus Cadila to make Gilead’s potential COVID-19 drug remdesivir

    India's Zydus Cadila to make Gilead's potential COVID-19 drug remdesivirIndian drugmaker Zydus Cadila said on Friday it signed a non-exclusive licensing pact with Gilead Sciences Inc to manufacture and market antiviral drug remdesivir, the first treatment to show improvement in COVID-19 trials. Zydus, listed as Cadila Healthcare, joins other Indian pharmaceutical companies Cipla Ltd, Jubilant Sciences Ltd and privately held Hetero Labs Ltd in signing non-exclusive pacts with Gilead for the drug. The drug, intravenously administered in hospitals, has already been approved for emergency use in severely-ill patients in the United States, India and South Korea.

    from Yahoo Finance https://ift.tt/3hlTD6W

  • Hedge Funds Aren’t Crazy About MongoDB, Inc. (MDB) Anymore

    Hedge Funds Aren’t Crazy About MongoDB, Inc. (MDB) AnymoreThe latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F […]

    from Yahoo Finance https://ift.tt/3fhgmiL

  • ‘Pull backs are going to be the new normal’ after worst sell-off since March: Strategist

    'Pull backs are going to be the new normal' after worst sell-off since March: StrategistNela Richardson, Edward Jones Investment Strategist, joins Yahoo Finance to discuss the market sell-off. She also weighs in on what investors can expect in the coming months as fears of a second wave of COVID-19 continue.

    from Yahoo Finance https://ift.tt/3dYnkJf

The Latest

  • The ASX 200 blue chip shares I would buy with $5,000 after the market crash

    ·

  • The list of market resources pinned to the top of the sub has been updated!

    ·

  • Financial statement inaccuracy

    ·

  • PFE | Pfizer and German partner BioNTech SE said Tuesday they’ve begun delivering doses of their coronavirus vaccine to US candidates with trials in Germany already underway.

    ·